Magle Group announces innovation sponsorship with leading life science incubator in Sweden

18/05/2022

The Magle Group’s sponsorship of the SmiLe incubator is part of the Group’s commitment to supporting early-stage companies develop and commercialize new ideas in life science

The sponsorship of SmiLe in 2022 is part of Magle Group’s commitment to being a group that is truly a partner in addressing the healthcare challenges in the world. As part of the sponsorship Magle Group will provide advisory and development support for innovation companies and aims to help companies navigate the complexities of product development in the life science sector.

“At Magle Chemoswed we understand the risk and complexity around the development of a pharmaceutical candidate. Our right first-time philosophy has been tested and proven over numerous projects. As a one-stop shop we offer fully integrated services from early screening, solid state analysis, risk assessments, process development, formulation, and production for clinical trials, tox testing, pre-clinical testing all the way to validation and commercial supply. By sharing our experiences and knowledge we believe that we can make a positive difference to SmiLe companies,” said Simon Jegou, Chief Strategy Officer, Magle Group.

"I am very pleased to announce our new gold sponsorship collaboration with Magle Chemoswed. They bring completely new and valuable expertise to our community and they complement our existing sponsors perfectly. I am convinced that this will be of great benefit to our member companies and I am very much looking forward to our cooperation," said Ebba Fåhraeus, CEO of SmiLe.

More information about SmiLe can be found here

About Us

The Magle Group aims to establish itself as a leader in high-quality life-changing healthcare innovations to meet medical needs through scientific excellence. The Magle Group is founded on strategic acquisitions aimed at driving growth and diversifying risk. Today, the Group includes two operational areas. Magle Chemoswed – a contract development and manufacturing organization (CDMO) with a strong reputation for its high-quality development and manufacturing expertise and Magle PharmaCept – an established sales and marketing company for development and direct sales of the Groups medical technology products. Learn more on www.maglechemoswed.com and https://maglegroup.com/ and www.maglepharmacept.com

Västra Hamnen Corporate Finance is the Company's certified advisor on Nasdaq First North Growth Market and can be reached at ca@vhcorp.se or +46 (0) 40 200 250.

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. You also have the option to opt-out of these cookies. For more information about the cookies we use, see our Privacy Policy & Cookie Policy.

Necessary

Always Enabled

Functional

Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.

Cookie	Duration	Description
_hjAbsoluteSessionInProgress	30 minutes	Hotjar sets this cookie to detect a user's first pageview session, which is a True/False flag set by the cookie.
__cf_bm	30 minutes	Cloudflare set the cookie to support Cloudflare Bot Management.

Performance

Analytics

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.

Cookie	Duration	Description
_ga	1 year 1 month 4 days	Google Analytics sets this cookie to calculate visitor, session and campaign data and track site usage for the site's analytics report. The cookie stores information anonymously and assigns a randomly generated number to recognise unique visitors.
_gat_gtag_UA_*	1 minute	Google Analytics sets this cookie to store a unique user ID.
_ga_*	1 year 1 month 4 days	Google Analytics sets this cookie to store and count page views.
_gid	1 day	Google Analytics sets this cookie to store information on how visitors use a website while also creating an analytics report of the website's performance. Some of the collected data includes the number of visitors, their source, and the pages they visit anonymously.
_hjFirstSeen	30 minutes	Hotjar sets this cookie to identify a new user’s first session. It stores the true/false value, indicating whether it was the first time Hotjar saw this user.
_hjRecordingEnabled	never	Hotjar sets this cookie when a Recording starts and is read when the recording module is initialized, to see if the user is already in a recording in a particular session.
_hjRecordingLastActivity	never	Hotjar sets this cookie when a user recording starts and when data is sent through the WebSocket.
_hjSessionUser_*	1 year	Hotjar sets this cookie to ensure data from subsequent visits to the same site is attributed to the same user ID, which persists in the Hotjar User ID, which is unique to that site.
_hjSession_*	30 minutes	Hotjar sets this cookie to ensure data from subsequent visits to the same site is attributed to the same user ID, which persists in the Hotjar User ID, which is unique to that site.

Others

Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.

Cookie	Duration	Description
_hjIncludedInSessionSample_1838733	2 minutes	Description is currently not available.